2013 best year, 2008 worst year forColoplast

For years it were very profitable times for the shareholders of Coloplast . Also without dividend payments the stock belongs to the outperformers of both the pharmaceutical sector as the Danish exchange. The received dividends increase the huge gains even further.

The matrix above shows Coloplast 's historical returns expressed in the different entry years in the left axis.

The year 2008 was the worst year for the company, with the stock losing about 18 percent in value. 2012 was the best year for the stock as it gained 67 percent in value. Measured since 2008 the total returns equals even plus 775 percent.

Over the current book year the total revenue will be 16,53 billion Danish Krone (consensus estimates). This is slightly more than 2017's revenue of 15,53 billion Danish Krone.

Historical revenues and results Coloplast plus estimates 2018

The analysts expect for 2018 a net profit of 3,94 billion Danish Krone. The majority of the analysts expects for this year a profit per share of 18,64 Danish Krone. So the price/earnings-ratio equals 34,22.

Per share the analysts anticipate on a dividend of 15,56 Danish Krone per share. Coloplast 's dividend yield thus equals 2,44 percent. The average dividend yield of the pharmaceutical companies is a limited 0,5 percent.

Based on the current number of shares Coloplast 's market capitalization equals 123,57 billion Danish Krone.

Historical stock prices Coloplast

At 11.37 the stock trades 1,47 percent lower at 637,8 Danish Krone.

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.